Antagonist Protocol in IVF

Can Antagonist Protocol be the Protocol of Choice in in Vitro Fertilization Patients?

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02335736

Enrollment

200

Registered

2015-01-12

Start date

2015-01-31

Completion date

2016-04-30

Last updated

2016-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

infertility

Brief summary

The antagonist protocol in a novel method of stimulation in the in vitro fertilization (IVF) patients. It has been tried in poor responders, polycystic ovary (PCO) patients and normal females undergoing IVF. Can it be used with the same efficacy in all patients?

Interventions

DRUGGonadotropins releasing hormone antagonist

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 44 Years

Healthy volunteers

Yes

Inclusion criteria

* age: 20- 44 years * Poor responder females according to Bologna criteria * Polycystic ovarian disease females according to Rotterdam criteria * Females with infertility causes other than poor responders, or PCO; male factor or tubal block

Exclusion criteria

* refusal to get enrolled in the study * cases of infertility due to severe male factor

Design outcomes

Primary

Measure	Time frame
number of oocytes collected and fertilized	6 months

Countries

Egypt

Contacts

Primary ContactDina M Dakhly, MD

dinadakhly@gmail.com01003498919

Backup Contactmohamed abdalla, MD

mohamedhassan100@hotmail.com01001721206

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026